
Release date: 2026-06-26 17:54:16 Article From: Lucius Laos Recommended: 234
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long relied on imports of high-quality generic medicines from countries such as China and India. The pharmaceutical and medical device market in Laos is regulated by the Food and Drug Bureau. In recent years, with increased openness and favorable policies, some pharmaceutical companies have chosen to set up factories in Laos, and the countrys pharmaceutical sector has shown certain development momentum. The following are the major pharmaceutical companies currently operating in Laos.
Lucius Pharmaceuticals was established in 2020 and is located at No. 26, Thongmang Village, Xaysettha District, Vientiane, the capital of Laos. The company is a legally approved pharmaceutical manufacturer by the Lao government.
Production scale: Lucius Pharmaceuticals' factory covers an area of approximately 210,000 square meters. The company now produces over 200 generic drug varieties, covering multiple therapeutic areas. As of June 2024, Lucius Pharmaceuticals has obtained marketing approvals for 54 anticancer drugs.
Product portfolio: Lucius Pharmaceuticals focuses on antineoplastic agents as its core product line, having developed generic versions of targeted therapies including sotorasib, osimertinib, cabozantinib, larotrectinib, lorlatinib, and crizotinib. In addition, the company's products also include antihypertensive drugs such as aprocitentan.
Market presence: Lucius Pharmaceuticals has expanded its business to 12 countries, including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Sri Lanka, Turkey, Japan, and China, and has established extensive partnerships.
Lao Alliance Pharmaceutical Group, founded in 2017, is a comprehensive pharmaceutical company integrating R&D, production, and sales. It occupies about 80 mu (approx. 5.3 hectares) and currently employs 243 staff. The company is one of the largest pharmaceutical enterprises in Laos and one of the three OTC drug manufacturers, holding about 27% of the Lao pharmaceutical market. Currently, the group is investing RMB 1.5 billion to build a new plant, with an expected annual output value of RMB 5 billion upon completion, which is poised to become the largest pharmaceutical factory in Southeast Asia.
The National Pharmaceutical Factory No. 2 is a state-owned pharmaceutical enterprise under the direct supervision of the Lao Ministry of Health. Established in the 1970s, it is one of the most comprehensive drug producers in Laos, with over 160 products including infusions, injections, oral tablets, oral capsules, oral syrups, ointments, and more.
In addition, Laos also has other state-owned manufacturers such as the National Pharmaceutical Factory No. 3.
Apart from the above, there are several other pharmaceutical companies in Laos, including ASEAN Food and Drug (Laos) Co., Ltd., Lao-Viet Pharmaceutical Factory, KPN Pharmaceutical Co., Ltd., and Lao Element Pharmaceutical, among others. These enterprises have all obtained official drug marketing approvals, and some of them specialize in the production of generic anticancer drugs.
Overall, the pharmaceutical industry in Laos remains in a developing stage, with a limited number of factories. However, companies like Lucius Pharmaceuticals are gradually expanding both domestic and international markets, driving the industry forward.
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed countries (extended to July 1, 2033), Laos has been legally permitted to produce ge···【more】
Recommended:94Release date: 2026-08-05
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos have gradually entered the view of Chinese cancer and chronic disease patients due ···【more】
Recommended:87Release date: 2026-08-04
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rapid growth in its generic pharmaceutical industry in recent years. Lucius Pharmac···【more】
Recommended:129Release date: 2026-07-31
Lucius Pharmaceutical is a modern pharmaceutical enterprise headquartered in Vientiane, the capital of Laos. The company was established in 2020, with its R&D and operational s···【more】
Recommended:126Release date: 2026-07-28
Lucius Pharmaceuticals Relocates from India to Laos: A Five-Year Development Journey of a Generic Drug CompanyRelocation Background and Strategic ShiftLucius Pharmaceuticals was fo···【more】
Recommended:201Release date: 2026-07-24
In recent years, Laos has gradually become a major global supply source for generic drugs, leveraging the WTO-granted patent exemption for least-developed countries. Among them, Lu···【more】
Recommended:160Release date: 2026-07-22
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020, with its headquarters located at No. 26, Thongmang Village···【more】
Recommended:179Release date: 2026-07-20
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was established in Vientiane, the capital of Laos, in 2020 and has been in operatio···【more】
Recommended:188Release date: 2026-07-17
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos' generic drug industry is rooted in unique international rule dividends. As a U···【more】
Recommended:285Release date: 2026-07-16
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease patients in China due to their significant price advantage. Leveraging the WTO pat···【more】
Recommended:176Release date: 2026-07-15
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulation adopts a centralized "one ministry, one department" management mod···【more】
Recommended:194Release date: 2026-07-14
Overview of Lao generic drug industryThe Lao generic drug industry started late but has developed rapidly in recent years. Relying on the WTO's patent waiver for least develope···【more】
Recommended:207Release date: 2026-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:864Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:824Release date: 2024-07-09
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic name: vibegron) is an oral, once-daily β3-adrenergic receptor agonist approved by ···【more】
Recommended:83Release date: 2026-08-06
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 previously untreated CLL/SLL patients aged 65 years and older, ibrutinib demonst···【more】
Recommended:86Release date: 2026-08-03
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the class of ALK inhibitors. Unlike traditional chemotherapy, it does not act by kill···【more】
Recommended:96Release date: 2026-07-30
Lucius Pharmaceuticals Quizartinib (Quizartinib) Has Been Launched(1) Quizartinib is an oral tablet. The recommended dose is once daily, one tablet per day (the specific dose is de···【more】
Recommended:116Release date: 2026-07-29
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies for DacomitinibRash and exfoliative skin reactions are highly characteristic adv···【more】
Recommended:147Release date: 2026-07-21
Lao PDR: Filgotinib Has Been LaunchedBefore initiating filgotinib treatment, strict screening for the following contraindications is mandatory; the presence of any one of these con···【more】
Recommended:146Release date: 2026-07-13
Lucius Pharmaceuticals' Pirtobrutinib Has Been LaunchedPirtobrutinib is an oral anticancer drug whose active ingredient is pirtobrutinib, belonging to the class of Bruton's···【more】
Recommended:175Release date: 2026-07-10
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagolix sodium (trade name LuciElag) for the treatment of moderate to severe pain associated with endometr···【more】
Recommended:190Release date: 2026-07-06
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strictly contraindicated in the following situations: ①hypersensitivity to bempedoic acid or any excipient···【more】
Recommended:175Release date: 2026-07-03
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended:212Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended:318Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended:639Release date: 2025-12-17

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643